Choice of antibiotics in late neonatal sepsis in the extremely low birth weight infant

Canadian Journal of Infectious Diseases

Volumn 14, Issue 1, 2003, Pages 28-31

  Allen, Tara R ^a   Da Silva, Orlando P ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Antibiotics; Neonate; Sepsis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFTIZOXIME; NETILMICIN; VANCOMYCIN;

ARTICLE; BACTERIUM CULTURE; BIRTH WEIGHT; BLOOD CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; HUMAN; INFANT MORTALITY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; NEWBORN MORTALITY; NEWBORN SEPSIS; TREATMENT PLANNING;

EID: 0037241929     PISSN: 11802332     EISSN: None     Source Type: Journal    
DOI: 10.1155/2003/510265     Document Type: Article

References (17)

1. Goldmann DA, Uskins WC. Control of nosocomial antimicrobial- resistant bacteria: A strategic priority for hospitals worldwide. Clin Infec Dis 1997;24(Suppl I):139-45.
2. Edmond MB, Ober JF, Weinbaum DL. Vancomycin-resistant Enterococcus faecium bacteria: Risk factors for infection. Clin Infect Dis 1995;20:1126-33.
3. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: A report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:63-71.
4. Cordero L, Sananes M, Ayers LW. Bloodstream infections in a neonatal intensive-care unit: 12 years' experience with an antibiotic control program. Infect Control Hosp Epidemiol 1999;20:242-6.
5. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics 2000;106:1387-90.
6. Isaacs D. Rationing antibiotic use in neonatal units. Arch Dis Child Fetal Neonatal Ed 2000;82:F1-2.
7. Sinowitz RL, Keyserling H, Walker TJ, Holland J, Jarvis WR. Epidemiology of vancomycin usage in a newborn intensive care unit. Pediatr Infect Dis J 1997;16:485-9.
8. Hammerberg O, Bialkowska-Hobranska H, Gregson D, Potters H, Gopaul D, Reid D. Comparison of blood cultures with corresponding venipuncture site cultures of specimens from hospitalised premature neonates. J Pediatr 1992;120:120-4.
9. Centers for Disease Control and Prevention. Preventing the spread of vancomycin resistance - a report from the Hospital Infection Control Practice Advisory Committee prepared by the Subcommittee on Prevention and Control of Antimicrobial- Resistant Microorganisms in Hospitals. Federal Register 1994;59:22758-63,
10. Matrai-Kovalskis Y, Greenberg D, Shinwell ES, Fraser D, Dagan R. Positive blood cultures for Coagulase-negative staphylococci in neonates: Does highly selective vancomycin usage affect outcome? Infection 1998;26:85-92.
11. Bryan CS, John GF, Pai MS, Austin TL. Gentamicin vs cefotaxime for therapy of neonatal sepsis: Relationship to drug resistance. Am J Dis Child 1985;139:1086-9.
12. Spritzer R, Kamp HJ, Dzoljic G, Sauer PJ. Five years of cefotaxime use in a neonatal intensive care unit. Pediatr Infect Dis J 1990;9:92-6.
13. Haertl R, Bandlow G. Molecular typing of Enterobacter cloacae by pulsed-field gel electrophoresis restriction fragment. J Hosp Infect 1993;25:109-16.
14. Modi N, Damjonovic V, Cooke RW. Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child 1987;62:148-51.
15. Verweij PE, Van Belkum A, Melchers WJ, Hoogkamp-Korstanje JA, Meis JF. Interrepeat fingerprinting of third-generation cephalosporin-resistant Enterobacter cloacae isolated during an outbreak in a neonatal intensive care unit. Infect Control Hosp Epidemiol 1995;16:25-9.
16. Venezia RA, Scarano FJ, Preston KE, et al. Molecular epidemiology of an SHV-5 extended-spectrum beta-lactamase in enterobacteriaceae isolated from infants in a neonatal intensive care unit. Clin Infect Dis 1995;21:915-23.
17. de Man P, Verhoeven BAN, Verbrugh HA, Vos MC, den Anker JN. Antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000;355:973-8.